WESTWEGO, Louisiana — Robin Phillip’s fresh haircut is dyed her favorite color — green. But beneath the dye job is a scar that runs along the side of her head, the result of two craniotomies. For ...

As of 2025, lawsuits are now underway against Pfizer, the manufacturer of Depo-Provera, filed by women who were diagnosed with meningioma after using the birth control shot. These cases allege that ...

Jenn BashamAssociate News EditorThe Food and Drug Administration recently added a black box warning to Depo-Provera, the popular injection contraceptive, after studies revealed that prolonged use of ...

The decision comes as Pfizer faces lawsuits from more than 1000 women who say the company knew about the risks and didn’t warn them. The agency signed off last week on a label update for 2 versions of ...

The judge appointed Chris Seeger as lead counsel and co-leads Ellen Relkin and Bryan Aylstock. More than 70 lawsuits against Pfizer allege Depo-Provera, an injectable birth control, has been linked to ...

Women in the UK are calling for a review of the Depo-Provera contraceptive injection after developing brain tumours they ...

Add Yahoo as a preferred source to see more of our stories on Google. Multiple studies have found a potential link between Depo-Provera birth control injections and meningioma tumors. More than a ...

Women injected with the Depo-Provera birth control shot are more than five-times more likely to be diagnosed with a type of brain tumors known as meningioma, according to a recent study. Several ...

Rodgers, in the Northern District of Florida, was assigned earlier this month to oversee the multidistrict litigation alleging that Depo-Provera, an injectable birth control, was linked to brain ...

A popular injectable birth control, Depo-Provera (medroxyprogesterone acetate) — also sold as Depo-SubQ Provera 104 — has long been favored for its 99% effectiveness and ease of use compared to daily ...

PENSACOLA, Fla.--(BUSINESS WIRE)--A Case Management Conference (CMC) in the Depo-Provera legal action against Pfizer Inc. (NYSE:PFE) will take place on Friday, 30 May at 9:00am CT in the United States ...